John P Brancaccio is of Cardiff Oncology, Inc.. Currently has a direct ownership of 12,260 shares of CRDF, which is worth approximately $48,059. The most recent transaction as insider was on Mar 22, 2021, when has been sold 3,000 shares (Common Stock) at a price of $10.95 per share, resulting in proceeds of $32,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.3K
0% 3M change
0% 12M change
Total Value Held $48,059

JOHN P BRANCACCIO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2021
BUY
Open market or private purchase
$32,850 $10.95 p/Share
3,000 Added 19.66%
12,260 Common Stock

Also insider at

HEPA
Hepion Pharmaceuticals, Inc. Healthcare
OKYO
OKYO Pharma Ltd Healthcare
JPB

John P Brancaccio

Edison, NJ

Track Institutional and Insider Activities on CRDF

Follow Cardiff Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

News

Receive news related to Cardiff Oncology, Inc.

Track Activities on CRDF